Literature DB >> 12208771

Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway.

Yohann Rautureau1, Gilles Toumaniantz, Sabrina Serpillon, Philippe Jourdon, Jean-Noël Trochu, Chantal Gauthier.   

Abstract

1. We have previously demonstrated that beta(3)-adrenoceptor (beta(3)-AR) stimulation induces endothelium-dependent vasorelaxation in rat aorta through the activation of an endothelial NO synthase associated with an increase in intracellular cGMP. The aim of the present study was to localise beta(3)-AR to confirm our functional study and to complete the signalling pathway of beta(3)-AR in rat aorta. 2. By RT-PCR, we have detected beta(3)-AR transcripts both in aorta and in freshly isolated endothelial cells. The absence of markers for adipsin or hormone-sensitive lipase in endothelial cells excluded the presence of beta(3)-AR from adipocytes. The localization of beta(3)-AR in aortic endothelial cells was confirmed by immunohistochemistry using a rat beta(3)-AR antibody. 3. To identify the G protein linked to beta(3)-AR, experiments were performed in rat pre-treated with PTX (10 microg kg(-1)), a G(i/0) protein inhibitor. The blockage of G(i/0) protein by PTX was confirmed by the reduction of vasorelaxation induced by UK 14304, a selective alpha(2)-AR agonist. The cumulative concentration-response curve for SR 58611A, a beta(3)-AR agonist, was not significantly modified on aorta rings from PTX pre-treated rats. 4. At the same level of contraction, the relaxations induced by 10 microM SR 58611A were significantly reduced in 30 mM-KCl pre-constricted rings (E(max)=16.7+/-8.4%, n=5), in comparison to phenylephrine (0.3 microM) pre-constricted rings (E(max)=49.11+/-11.0%, n=5, P<0.05). In addition, iberotoxin (0.1 microM), glibenclamide (1 microM) and 4-aminopyridine (1 mM), selective potassium channels blockers of K(Ca), K(ATP), and K(v) respectively, decreased the SR 58611A-mediated relaxation. 5. We conclude that beta(3)-AR is preferentially expressed in rat aortic endothelial cells. Beta(3)-AR-mediated aortic relaxation is independent of G(i/0) proteins stimulation, but results from the activation of several potassium channels, K(Ca), K(ATP), and K(v).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12208771      PMCID: PMC1573490          DOI: 10.1038/sj.bjp.0704867

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

Review 1.  Beta3-adrenoceptors in the cardiovascular system.

Authors:  C Gauthier; D Langin; J L Balligand
Journal:  Trends Pharmacol Sci       Date:  2000-11       Impact factor: 14.819

2.  Beta-3 adrenergic stimulation of L-type Ca(2+) channels in rat portal vein myocytes.

Authors:  P Viard; N Macrez; F Coussin; J L Morel; J Mironneau
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 3.  Vascular adrenoceptors: an update.

Authors:  S Guimarães; D Moura
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

Review 4.  Calcium channels, potassium channels, and voltage dependence of arterial smooth muscle tone.

Authors:  M T Nelson; J B Patlak; J F Worley; N B Standen
Journal:  Am J Physiol       Date:  1990-07

5.  Biosynthesis of endothelium-derived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclase.

Authors:  B Mayer; K Schmidt; P Humbert; E Böhme
Journal:  Biochem Biophys Res Commun       Date:  1989-10-31       Impact factor: 3.575

Review 6.  The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor.

Authors:  J G Granneman
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-02       Impact factor: 4.310

7.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

8.  Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.

Authors:  J N Trochu; V Leblais; Y Rautureau; F Bévérelli; H Le Marec; A Berdeaux; C Gauthier
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 9.  Potassium channel function in vascular disease.

Authors:  C G Sobey
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

10.  Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve.

Authors:  K S Cook; H Y Min; D Johnson; R J Chaplinsky; J S Flier; C R Hunt; B M Spiegelman
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

View more
  18 in total

Review 1.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

2.  beta-adrenoceptor mediated responses in rat pulmonary artery: putative role of TASK-1 related K channels.

Authors:  Detlef Bieger; Kakoli Parai; Carol Ann Ford; Reza Tabrizchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-25       Impact factor: 3.000

3.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

4.  Involvement of Gi protein-dependent BKCa channel activation in β2-adrenoceptor-mediated dilation of retinal arterioles in rats.

Authors:  Asami Mori; Ayumi Taniai; Mami Hasegawa; Kenji Sakamoto; Tsutomu Nakahara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-05       Impact factor: 3.000

Review 5.  Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.

Authors:  An L Moens; Ronghua Yang; Vabren L Watts; Lili A Barouch
Journal:  J Mol Cell Cardiol       Date:  2010-02-23       Impact factor: 5.000

6.  Different β-adrenoceptor subtypes coupling to cAMP or NO/cGMP pathways: implications in the relaxant response of rat conductance and resistance vessels.

Authors:  N Flacco; V Segura; M Perez-Aso; S Estrada; J F Seller; F Jiménez-Altayó; M A Noguera; P D'Ocon; E Vila; M D Ivorra
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  Atypical beta-adrenoceptors, different from beta 3-adrenoceptors and probably from the low-affinity state of beta 1-adrenoceptors, relax the rat isolated mesenteric artery.

Authors:  Hanna Kozłowska; Urszula Szymska; Eberhard Schlicker; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

8.  ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.

Authors:  Nataraj Brahmadevara; Angus M Shaw; Allan MacDonald
Journal:  Br J Pharmacol       Date:  2004-06       Impact factor: 8.739

9.  Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats.

Authors:  Mohamed Yassine Mallem; Gilles Toumaniantz; Sabrina Serpillon; Freddy Gautier; Marc Gogny; Jean-Claude Desfontis; Chantal Gauthier
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

10.  Mixed beta3-adrenoceptor agonist and alpha1-adrenoceptor antagonist properties of nebivolol in rat thoracic aorta.

Authors:  Bertrand Rozec; Thuy Tran Quang; Jacques Noireaud; Chantal Gauthier
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.